COMP <GO>
EPSN vs XOM // NET PROFIT MARGIN
Epsilon Energy Ltd. Common Share (NASDAQ) VS. Exxon Mobil Corporation (NYSE) • 15-METRIC TALLY: EPSN 1
— XOM 4
■ METRIC PARITY
LAST: $6.42 (+0.47%) • MKT CAP: $194.4M
net-margins
—
LAST: $183.29 (+0.70%) • MKT CAP: $753.67B
net-margins
7.57%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EPSN VS. XOM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EPSN | XOM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -7.20% | 9.86% | -17.06 | XOM | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 13.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 10.61% | 2.51% | +8.10 | EPSN | /fcf-yield <GO> |
| Operating Margin | — | 10.96% | — | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | — | 7.57% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -4.40% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.20% | -2.20 | XOM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.65 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.22% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.3 | 67.1 | -0.77 | XOM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.28 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 14.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $194.4M | $753.67B | -$753.48B | XOM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EPSN REV | XOM REV | EPSN GROSS % | XOM GROSS % | EPSN FCF | XOM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $332.24B | — | — | $20.6M | $23.61B |
| FY 2024 | $0 | $349.58B | — | — | $16.8M | $30.72B |
| FY 2023 | $0 | $344.58B | — | — | $18.2M | $33.45B |
| FY 2022 | — | $413.68B | — | — | — | $58.39B |
| FY 2021 | — | $285.64B | — | — | — | $36.05B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EPSN // BETA —
XOM // BETA 0.28